| System Biosciences | ||
| pPACK-SPIKE™ Omicron (B.1.1.529) Variant Lentivector Packaging Mix | ||
| CVD19-660A-1 | CVD19-665A-1 | CVD19-669A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ Delta (B.1.617.2) Variant Lentivector Packaging Mix | ||
| CVD19-650A-1 | CVD19-655A-1 | CVD19-659A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ Beta (B.1.351) Variant Lentivector Packaging Mix | ||
| CVD19-640A-1 | CVD19-645A-1 | CVD19-649A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ B.1.525 Variant Spike Protein Lentivector Packaging Mix | ||
| CVD19-620A-1 | CVD19-625A-1 | CVD19-629A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ B.1.429 (CAL.20C) Variant Spike Protein Lentivector Packaging Mix | ||
| CVD19-610A-1 | CVD19-615A-1 | CVD19-619A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ B.1.1.7 UK Variant Spike Protein Lentivector Packaging Mix | ||
| CVD19-590A-1 | CVD19-595A-1 | CVD19-599A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ P1 Variant Spike Protein Lentivector Packaging Mix | ||
| CVD19-630A-1 | CVD19-635A-1 | CVD19-639A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix | ||
| CVD19-560A-1 | CVD19-570A-1 | CVD19-575A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix | ||
| CVD19-530A-1 | CVD19-540A-1 | CVD19-550A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE™ SARS-CoV-2 “S” Pseudotype Lentivector Packaging Mix | ||
| CVD19-500A-1 | CVD19-510A-1 | CVD19-520A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE B.1.351 RBD Mutations Lentivector Packaging Mix | ||
| CVD19-580A-1 | CVD19-585A-1 | CVD19-589A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
| pPACK-SPIKE B.1.351 S1 Mutations (RBD+D614G) Lentivector Packaging Mix | ||
| CVD19-600A-1 | CVD19-605A-1 | CVD19-609A-KIT |
| 10 Reactions | 25 Reactions | 1 Kit |
COVID-19 Vaccine and Drug Development
| Supplier | Code | Name |
| System Biosciences | CVD19-220A-1 | HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line |
| System Biosciences | CVD19-200A-1 | HEK293 ACE2 Stable Cell Line |
| System Biosciences | CVD19-260A-1 | HEK293 ACE2 NRP1 Overexpression Stable Cell Line |
| Supplier | Code | Name |
| Genetex | GTX300122 |
Neutralization Assay Panel Including 5 SARS-CoV-2 RBD proteins (4 variants) + 1 control antibody |
| Signalchem | C19SD-N887 | 2019-nCoV Neutralization ELISA KIT |
| Cusabio | CSB-EL33243HU | SARS-CoV-2 Neutralizing Antibody ELISA Kit |
| Elab | E-EL-E606 | SARS-CoV-2 Neutralization Antibody ELISA Kit |
| Elab | E-EL-E608 | SARS-CoV-2 Neutralization Antibody ELISA Kit Semi-Quantitative Assay |
| Supplier | Name | Code |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike Neutralizing Antibody, Rabbit Mab | 40592-R118 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike Neutralizing Antibody, Rabbit Mab | 40592-R117 |
| Sino Biological | SARS-CoV / SARS-CoV-2 Spike antibody, Chimeric MAb | 40150-D002 |
| Sino Biological | SARS-CoV / SARS-CoV-2 Spike antibody, Chimeric MAb | 40150-D001 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing Antibody, Mouse MAb | 40591-MM43 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike RBD Neutralizing Antibody, Mouse MAb | 40592-MM57 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike Neutralizing Antibody, Rabbit Mab | 40592-R001 |
| Cusabio | SARS-CoV-2 Spike Neutralizing Antibody (16-685aa) chimeric clone H6 MAb | CSB-RA33245A1GMY |
| Cusabio | SARS-CoV-2 Spike RBD (319-541aa) Neutralizing Nanobody clone A1 MAb | CSB-RA33245A2GMY |
| Genetex | SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022] | GTX01555 |
| Genetex | SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022-RB] | GTX01556 |
| Genetex | Neutralizing Spike RBD antibody [HL1002] Rabbit Monoclonal – to all variants | GTX635692 |
| Signalchem |
Anti 2019-nCoV Spike Protein Llama heavy-chain Nanobody – Human IgG Fc | C19S1-641HL |
| Signalchem | Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-644HL |
| Signalchem | Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-643HL |
| Signalchem | Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-642HL |
| Signalchem | Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-654L |
| Signalchem | Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-653L |
| Signalchem | Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-652L |
Compound Library
| Supplier | Code | Name |
| ApexBio | L1050 | DiscoveryProbe™ Anti-Virus Compound Library (List of compounds) |
| ApexBio | L1021 | DiscoveryProbe™ FDA-approved Drug Library (List of compounds) |
| Selleckchem | L7000 | Antiviral Compound Library |
| Selleckchem | L7200 | Nucleoside Analogue Library |
Coronavirus proteases substrates
| Supplier | Code | Name |
| AAT | 13542 | Covidyte™ IF670 – Coronavirus protease fluorescent substrate |
| AAT | 13543 | Covidyte™ IF670 – Coronavirus protease fluorescent substrate |
| AAT | 13538 | Covidyte™ ED450 – Coronavirus protease fluorescent substrate |
| AAT | 13537 | Covidyte™ ED450 – Coronavirus protease fluorescent substrate |
| AAT | 13536 | Covidyte™ EN450 – Coronavirus protease fluorescent substrate |
| AAT | 13535 | Covidyte™ EN450 – Coronavirus protease fluorescent substrate |
| AAT | 13540 | Covidyte™ TF670 – Coronavirus protease fluorescent substrate |
| AAT | 13541 | Covidyte™ TF670 – Coronavirus protease fluorescent substrate |
ACE2 substrates for screening ACE2 inhibitors.
Individual Inhibitors
Your first choice for scientific solutions
Find out more
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations